New Head of Trump’s Cancer Panel Raised Questions on Vaccine-Cancer Links and ‘Turbo Cancer’
Yale epidemiologist Harvey Risch is set to chair the President’s Cancer Panel under the Trump administration, a development that has drawn attention due to his past public statements. Risch has previously entertained connections between COVID-19 vaccines and a phenomenon termed ‘turbo cancer,’ and has also promoted the use of drugs like ivermectin and hydroxychloroquine.
This appointment comes at a time when discussions around public health and cancer research are particularly sensitive, with ongoing debates about vaccine efficacy and potential side effects. The panel’s leadership by Risch raises questions about the scientific direction and public discourse on cancer prevention and treatment moving forward, particularly concerning his previously expressed views.
This article was generated by Gemini AI as part of the automated news generation system.